Article Information
History
- May 19, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Du-San Baek1,*,†,
- Ye-Jin Kim1,*,
- Wei Li1,
- Bernard JC Macatangay1,
- Joshua C. Cyktor1,
- Margaret G. Hines1,
- John W. Mellors1,2 and
- Dimiter S. Dimitrov1,2,†
- 1Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
- 2Abound Bio, Pittsburgh, PA, USA
- ↵†Correspondence: dub5{at}pitt.edu, mit666666{at}pitt.edu
↵* These authors contributed equally to this work.
Posted May 19, 2022.
Discovery and pre-clinical evaluation of antibodies to the NKG2A inhibitory receptor
